Coherus BioSciences Inc (CHRS) earnings · rev $26.6M
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
This CHRS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
When the next CHRS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for CHRS. We will not invent a beat or miss.
Not investment advice. Full CHRS research stays on the stock page; the tape stays on the quote page.
Not investment advice.